Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/9584
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | PIEDBOIS, P. | - |
dc.contributor.author | BUYSE, Marc | - |
dc.date.accessioned | 2009-05-04T08:43:26Z | - |
dc.date.issued | 2008 | - |
dc.identifier.citation | CURRENT OPINION IN ONCOLOGY, 20(4). p. 466-471 | - |
dc.identifier.issn | 1040-8746 | - |
dc.identifier.uri | http://hdl.handle.net/1942/9584 | - |
dc.description.abstract | Purpose of review The purpose of this review is to discuss recently published work on endpoints for early and advanced colorectal cancer, as well as the statistical approaches used to validate surrogate endpoints. Recent findings Most attempts to validate surrogate endpoints have estimated the correlation between the surrogate and the true endpoint, and between the treatment effects on these endpoints. The correlation approach has made it possible to validate disease-free survival and progression-free survival as acceptable surrogates for overall survival in early and advanced disease, respectively. Summary The search for surrogate endpoints will intensify over the coming years. In parallel, efforts to either standardize or extend the endpoints or both will improve the reliability and relevance of clinical trial results. | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.subject.other | colorectal cancer; disease-free survival; overall survival; progression-free survival; surrogate endpoints | - |
dc.title | Endpoints and surrogate endpoints in colorectal cancer: a review of recent developments | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 471 | - |
dc.identifier.issue | 4 | - |
dc.identifier.spage | 466 | - |
dc.identifier.volume | 20 | - |
local.format.pages | 6 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | [Buyse, Marc] IDDI, B-1340 Louvain, Belgium. [Piedbois, Pascal] Hop Henri Mondor, Dept Med Oncol, F-94010 Creteil, France. | - |
local.type.refereed | Refereed | - |
local.type.specified | Review | - |
dc.bibliographicCitation.oldjcat | A1 | - |
dc.identifier.doi | 10.1097/CCO.0b013e32830218fe | - |
dc.identifier.isi | 000257379500019 | - |
item.accessRights | Closed Access | - |
item.validation | ecoom 2010 | - |
item.contributor | PIEDBOIS, P. | - |
item.contributor | BUYSE, Marc | - |
item.fulltext | No Fulltext | - |
item.fullcitation | PIEDBOIS, P. & BUYSE, Marc (2008) Endpoints and surrogate endpoints in colorectal cancer: a review of recent developments. In: CURRENT OPINION IN ONCOLOGY, 20(4). p. 466-471. | - |
crisitem.journal.issn | 1040-8746 | - |
crisitem.journal.eissn | 1531-703X | - |
Appears in Collections: | Research publications |
SCOPUSTM
Citations
20
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
21
checked on Jul 18, 2024
Page view(s)
60
checked on May 23, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.